Novel histopathological biomarkers in prostate cancer: implications and perspectives

P Kiełb, K Kowalczyk, A Gurwin, Ł Nowak, W Krajewski… - Biomedicines, 2023 - mdpi.com
Prostate cancer (PCa) is the second most frequently diagnosed cancer in men. Despite the
significant progress in cancer diagnosis and treatment over the last few years, the approach …

[HTML][HTML] Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome …

J Tang, GT Lam, RD Brooks, M Miles, Z Useckaite… - Cancer Letters, 2024 - Elsevier
The highly heterogenous nature of colorectal cancer can significantly hinder its early and
accurate diagnosis, eventually contributing to high mortality rates. The adenoma-carcinoma …

Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease …

BD Nturubika, CM Guardia, DC Gershlick… - British Journal of …, 2024 - nature.com
Background This study focuses on the role of lysosomal trafficking in prostate cancer, given
the essential role of lysosomes in cellular homoeostasis. Methods Lysosomal motility was …

Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression

J Lazniewska, KL Li, IRD Johnson, A Sorvina… - Scientific reports, 2023 - nature.com
Prostate cancer (PCa) development and progression relies on the programming of glucose
and lipid metabolism, and this involves alterations in androgen receptor expression and …

Prediction of prostate cancer biochemical and clinical recurrence is improved by IHC-assisted grading using Appl1, Sortilin and Syndecan-1

JM Logan, AM Hopkins, C Martini, A Sorvina, P Tewari… - Cancers, 2023 - mdpi.com
Simple Summary A novel biomarker panel (Appl1, Sortilin and Syndecan-1) was
demonstrated as a strong independent predictor for both clinical and biochemical …

Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers

JM Logan, C Martini, A Sorvina, IRD Johnson… - Scientific Data, 2024 - nature.com
The diagnosis of prostate cancer using histopathology is reliant on the accurate
interpretation of prostate tissue sections. Current standards rely on the assessment of …

[HTML][HTML] Altered endosomal-lysosomal biogenesis in melanoma

GT Lam, A Sorvina, C Martini, S Prabhakaran… - Neoplasia, 2023 - Elsevier
Cutaneous melanoma is the deadliest form of skin neoplasm and its high mortality rates
could be averted by early accurate detection. While the detection of melanoma is currently …

Insights into melanoma clinical practice: a perspective for future research

GT Lam, C Martini, T Brooks, S Prabhakaran… - Cancers, 2023 - mdpi.com
Simple Summary This study acknowledges the challenges in melanoma diagnosis and the
need for new technology that aids clinical decision making. Biomarkers that can accurately …

Intracellular osteopontin promotes the release of TNFα by mast cells to restrain neuroendocrine prostate cancer

R Sulsenti, GB Scialpi, B Frossi, L Botti… - Cancer Immunology …, 2024 - aacrjournals.org
Neuroendocrine prostate cancer (NEPC) is an aggressive form of prostate cancer that
emerges as tumors become resistant to hormone therapies or, rarely, arises de novo in …

[HTML][HTML] Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread

A Sorvina, C Martini, S Prabhakaran, JM Logan… - Pathology, 2023 - Elsevier
The presence of intraductal carcinoma of the prostate (IDCP) correlates with late-stage
disease and poor outcomes for patients with prostatic adenocarcinoma, but the accurate and …